Irreversible neurologic complications of metrizamide myelography

Kimford Meador, William J. Hamilton, Taher A.M. El Gammal, K. C. Demetropoulos, Fenwick T. Nichols

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Metrizamide, a major contrast agent for myelographic procedures, has rarely been reported to cause irreversible neurologic complications. The major transient neurologic alterations include neuropsychological reactions, generalized tonic-clonic seizures, and headaches. Two cases of irreversible spinal neurologic deficits resulting from metrizamide myelography are reported, and the factors that may increase the risks of complications in metrizamide myelographic studies are discussed, including preexisting dehydration, patient positioning, and the concentration of contrast agent.

Original languageEnglish (US)
Pages (from-to)817-821
Number of pages5
JournalNeurology
Volume34
Issue number6
DOIs
StatePublished - Jun 1984

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Irreversible neurologic complications of metrizamide myelography'. Together they form a unique fingerprint.

  • Cite this

    Meador, K., Hamilton, W. J., El Gammal, T. A. M., Demetropoulos, K. C., & Nichols, F. T. (1984). Irreversible neurologic complications of metrizamide myelography. Neurology, 34(6), 817-821. https://doi.org/10.1212/wnl.34.6.817